Additional file 5: of A pharmacogenetic signature of high response to Copaxone in late-phase clinical-trial cohorts of multiple sclerosis Colin Ross Fadi Towfic Jyoti Shankar Daphna Laifenfeld Mathis Thoma Matthew Davis Brian Weiner Rebecca Kusko Ben Zeskind Volker Knappertz Iris Grossman Michael Hayden 10.6084/m9.figshare.c.3792238_D8.v1 https://springernature.figshare.com/articles/journal_contribution/Additional_file_5_of_A_pharmacogenetic_signature_of_high_response_to_Copaxone_in_late-phase_clinical-trial_cohorts_of_multiple_sclerosis/5057395 The eleven-SNP model coefficients, odds ratios with 95% Bayesian confidence intervals and posterior inclusion probabilities. (DOCX 15 kb) 2017-05-31 05:00:00 Pharmacogenetics Copaxone Glatiramer acetate Treatment-response Inter-individual variability Multiple sclerosis Multi-SNP signature Multivariable Bayesian modeling